For a refined look that lasts, try Restylane®

Every one of us is unique, not just in terms of looks, but in our own individual goals and needs. We want results that improve our appearance while preserving our own unique beauty. Restylane offers the world’s most diverse range of fillers1 that provides instant and natural results for long-term satisfaction. Restylane empowers you to enhance and maintain your looks – your way.

Restylane is the original hyaluronic acid dermal filler with over 40 million treatments to date. Restylane fillers provide you with shape and contours through lift, fill and volume.2

Lift

Our Restylane Lift products shape your facial contours when you need a lift to reduce signs of aging or when you wish to sharpen your looks.

Site Factory admin
The Galderma aesthetics range, Restylane Lyft and Deyfne - a look at fillers, treatments to lift and define your favourite features
dd

Fill

Our Restylane Fill products fill lines and wrinkles for a refined result. 

Site Factory admin
The Galderma aesthetics range, RESTYLANE and Restylane Refyne - to fill lines and wrinkles
fill

Volumize

Our Restylane Volumize products create volume and softness in your face, to enhance your cheeks or lips, or to regain volume lost with age. 

Site Factory admin
The Galderma aesthetics range, Restylane Volyme - fillers, treatments focused on adding volume
ss

Introducing: Restylane Eyelight for undereye hollows

Restylane Eyelight fills in the undereye area to help people look more refreshed, while maintaining a natural look and feel.1,2*

  • 87% of patients (clinical trial participants) thought they looked less tired 3 months after treatment.
saranya.r
Olga Eyelight
Olga Eyelight

100%

of patients saw improvement after treatment 3

97%

of patients were satisfied with their results 4

96%

of patients thought their results looked natural 5

FREQUENTLY ASKED QUESTIONS

As Restylane is a non-permanent injectable hyaluronic acid product, the effect gradually diminishes with time. In order to maintain the aesthetic result, additional treatments, or top-up treatments (see below), are recommended. Results may vary depending on the treatment area.

Since Restylane filler treatments are long-lasting but not permanent, it is recommended to have top-up treatment for maintaining the results achieved in the initial treatment. Top-up treatments will most likely require lower volumes of hyaluronic acid, depending on the injection area and the time gaps between the treatments. 

•    Avoid applying make-up to the skin immediately after treatment.
•    Light cover up may be used to conceal any remaining redness after approximately 24 hours.
•    A yellow-toned concealer may be used to hide signs of bruising.
•    In order to cover up any redness, a concealer with a slight green/yellow tone is recommended.

The most common side effects include treatment site reactions such as swelling, bruising, redness, pain and tenderness. These side effects generally disappear within one week after injection. Other potential side effects can occur with dermal filler injections. You should discuss the potential treatment risks with your healthcare practitioner.
 

Restylane is manufactured by Galderma. Galderma is a pharmaceutical company with over 6,000 employees worldwide. The company specializes in dermatology and is present in more than 100 countries. To read more about Galderma visit About Galderma

Skin insights

Our portfolio of products

Galderma has developed a diverse portfolio of products that work holistically together.

Image
sss

Refresh

Refresh your skin from within with a boost of deep hydration, for a refreshed and vibrant look that lasts.

Image
dd

Renew

Renew the structure of your skin with a collagen activator that gradually builds the foundation of the youthful, firmer you.

References

  1. Data on file (MA-33939).; Öhrlund A. Poster presented at AMWC 2019.
  2. Öhrlund A. Poster presented at AMWC 2019.; Data on file (MA-34675); Data on file (MA-39680).
  3. Swift A et al. Clin Cosmet Investig Dermatol 2017;10:229–238.
  4. Philipp-Dormston et al. Dermatol Surg 2018;44(6):826–832.
  5. Rzany B et al. Dermatol Surg 2012;38:1153–1161.